NEWSROOM

biopharmaceutical

Summary of Concussion

Mar 30, 2023

Phoenix, Arizona, March 30, 2023 Introduction Have you ever hit your head and felt a little dizzy or confused afterwards? If so, you may have experienced a concussion. A concussion is a type of brain injury caused by a blow to the head or a violent shaking of the head and body. It is a common injury, particularly among athletes and those who engage in high-impact activities. In this article, we'll explore what a concussion is, its causes, symptoms, diagnosis, treatment, recovery,...

Odyssey Health, Inc. Preparing for a Phase II Pharmaceutical Concussion Treatment

Mar 30, 2023

Las Vegas, NV, March 30, 2023 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on creating unique, life-enhancing medical products, is developing a novel neuropharmaceutical treatment for mild Traumatic Brain Injury (mTBI) also known as a concussion. Recently, the world’s leading research agency, the National Institutes of Health (NIH), acknowledged that Chronic Traumatic Encephalopathy (CTE) is caused by repetitive head trauma,...

SOFTWARE EFFECTIVE SOLUTIONS “MEDCANA” (OTC: SFWJ) RETAINS INTERNATIONAL MONETARY FOR INVESTOR RELATIONS, CAPITAL FORMATION, AND OTHER STRATEGIC SERVICES

Mar 23, 2023

New Orleans, Louisiana, March 23, 2023 -- McapMediaWire -- Software Effective Solutions, (OTC Pink: SFWJ) (“The Company”, “SFWJ”) is pleased to announce it has entered into a formal agreement with International Monetary (www.intlmonetary.com), a merchant bank based in Newport Beach, CA, who will assist Software Effective Solutions Corporation in identifying new business prospects and strategic partnerships, as well as source capital so the company can continue to expand. Jose Gabriel...

Odyssey Health, Inc. Forms Community-Based Partnership with David R. Metcalf Foundation for Military Concussion Research

Feb 7, 2023

Las Vegas, NV, Feb 07, 2023 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today announces a Community-Based Partnership (CBP) with the David R. Metcalf Invisible Wounds Foundation, a non-profit organization that advances brain health care for active duty military and veterans by addressing traumatic brain injury (TBI) and suicide prevention among Naval Special Warfare...

Software Effective Solutions (OTC: SFWJ) Secures Distribution Agreement with Netafim, World’s Leading Drip Irrigation Technology Firm

Jan 12, 2023

New Orleans, Louisiana, January 12, 2023 -- McapMediaWire -- Software Effective Solutions, (OTC Pink: SFWJ) (“The Company”, “SFWJ”) DBA Medcana’s Eko2o announces it has begun operations and has secured a distribution agreement with Netafim (https://www.Netafim.com), the world’s leading drip irrigation technology company with a focus on driving mass adoption of smart irrigation solutions to fight scarcity of food, water and land. It was recently announced that Medcana has...

Odyssey Health, Inc. To Develop Intranasal Field- Deliverable Nerve Agent Antidote

Jan 12, 2023

Las Vegas, NV, January 12, 2023 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, announces the launch of a concept phase to develop an intra-nasal field-deliverable nerve agent antidote. Chemical warfare using organophosphate nerve agents is a threat worldwide. The risk could not be higher for civilians and military personnel operating in conflict areas like Ukraine. Nerve...

Odyssey Health, Inc. Provides a Year End Update on Company and Corporate Outlook for 2023

Dec 19, 2022

Las Vegas, NV, December 19, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing life-enhancing medical products, today presents a Company update and recap of its product development programs. The Company has medical products in development which it intends to move forward in their respective clinical programs with the goal of FDA submission and commercialization. “We are extremely pleased with the progress our...

Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development

Nov 23, 2022

Las Vegas, NV, November 23, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today presents a Company update and recap of its concussion drug development program. Concussions represent an ‘unmet’ medical need and affect tens of millions worldwide. Odyssey acquired the intellectual property and all rights to the concussion drug in March 2021. Since the acquisition, Odyssey...

Software Effective Solutions’ (OTC: SFWJ) Medcana Subsidiaries Launch Construction Proceedings for Multiple Greenhouse Operations in Colombia

Nov 16, 2022

New Orleans, Louisiana, November 16, 2022 -- McapMediaWire -- Software Effective Solutions, (OTC Pink: SFWJ) (“The Company”, “SFWJ”) DBA Medcana announces that construction operations of its five investment companies are proceeding as planned. Field tests, final greenhouse designs and placements have been completed. Also, Ministry of Justice and Anti-Narcotics audit was completed and passed, as expected. In the past month, field tests of microclimates have proceeded as planned, yielding...

Odyssey Health, Inc. Schedules Annual Meeting of Stockholders

Nov 15, 2022

Las Vegas, NV, November 15, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving medical products, today announced it plans to hold the Annual Meeting of Stockholders of Odyssey Health, Inc. on January 12, 2023. To be considered at the annual meeting, any stockholder proposals must be received at the principal executive offices of the Company, 2300...

Software Effective Solutions’ (OTC: SFWJ) Medcana Acquires Controlling Stake in Eko2o Environmental

Nov 3, 2022

New Orleans, Louisiana, November 3, 2022 -- McapMediaWire -- Software Effective Solutions, (OTC Pink: SFWJ) (“The Company”, “SFWJ”) subsidiary Medcana has acquired a controlling stake in Eko2o Environmental Solutions S.A.S. of Medellin, Antioquia. a company focused on developing infrastructure for agriculture, primarily with greenhouse construction and irrigation systems in Colombia and South America. With this acquisition, the Company is expanding its infrastructure and overall...

Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team

Nov 3, 2022

Las Vegas, NV, November 03, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving medical products, is pleased to announce its continued commitment to the newly formed entity, Odyssey NeuroPharma, with the expansion of its executive team. Joining the executive team at Odyssey NeuroPharma to advance Odyssey’s concussion treatment, and Niemann-Pick...

Odyssey Health Inc. Files Full US Patent Application on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device

Nov 1, 2022

Las Vegas, NV, November 01, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), announces that it has filed for United States and global patent protection on its novel breath-propelled, intranasal brain-drug delivery device (“Nasal Device”). As announced, Odyssey’s recently completed Phase I study to treat concussion successfully used Odyssey’s Nasal Device and drug combination. Odyssey designed the Nasal Device with...

(CORRECTION) Software Effective Solutions Subsidiary MEDCANA (OTC: SFWJ) Announces Successful Launch of Test Greenhouses for Microclimates and Genetics with Colombia Partner Firms

Oct 28, 2022

New Orleans, Louisiana, October 27, 2022 -- McapMediaWire -- Software Effective Solutions, (OTC Pink: SFWJ) (“The Company”, “SFWJ”) subsidiary Medcana is pleased to announce the successful launch of test greenhouses for microclimates and genetics with five partner firms in Colombia, South America. With significantly better economics than the US and Canada, a central location for exportation to major markets, and prime cultivation characteristics, Colombia is believed by many to have...

Software Effective Solutions Subsidiary MEDCANA (OTC: SFJW) Announces Successful Launch of Test Greenhouses for Microclimates and Genetics with Colombia Partner Firms

Oct 27, 2022

New Orleans, Louisiana, October 27, 2022 -- McapMediaWire -- Software Effective Solutions, (OTC Pink: SFWJ) (“The Company”, “SFWJ”) subsidiary Medcana is pleased to announce the successful launch of test greenhouses for microclimates and genetics with five partner firms in Colombia, South America. With significantly better economics than the US and Canada, a central location for exportation to major markets, and prime cultivation characteristics, Colombia is believed by many to have...

Odyssey Health, Inc. Forms Pharmaceutical Subsidiary Focused on Treating Neurological Diseases

Oct 11, 2022

Las Vegas, NV, October 11, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, announces the formation of Odyssey Neuropharma, Inc., a wholly owned subsidiary, focused on developing drugs to treat neurological disorders. The blood-brain barrier (BBB) represents a significant obstacle for drug delivery to the brain. Many drugs have failed in neuroscience research due to the...

Odyssey Health, Inc. Provides Recap on Concussion Drug Development

Oct 6, 2022

Las Vegas, NV, October 6, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today presents a recap of their concussion drug development program. Concussions represent an ‘unmet’ medical need and affect millions worldwide. Repetitive concussions can increase the risk of developing Chronic Traumatic Encephalopathy (CTE) and other neuropsychiatric disorders. Odyssey acquired...

SOFTWARE EFFECTIVE SOLUTIONS, INC. CORPORATE UPDATE TO SHAREHOLDERS AND ANNOUNCES QUALIFIED TIER 1 – FORM 1A REGISTRATION STATEMENT

Oct 6, 2022

New Orleans, Louisiana, October 6, 2022 -- McapMediaWire -- Software Effective Solutions, d/b/a as Medcana Inc. (OTC Pink: SFWJ) ("The Company") ($SFWJ) gives a corporate update. “The Company and management team have been working very diligently over the last several weeks to ensure all the filings, disclosures, financials, and corporate information are up-to-date and have filed a Form 1-A Offering Statement. We are pleased with the progress and are pleased to be qualified and...

Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Development Program

Sep 30, 2022

Las Vegas, NV, Sept. 30, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing a unique drug to treat concussion has decided to dissolve its sports advisory board. The sports advisory members have been outspoken advocates for concussion prevention and for the importance of finding responsible treatments. We created the advisory board to increase awareness of our mission to bring a much-needed pharmaceutical for a...

Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug

Sep 28, 2022

Las Vegas, NV, Sept. 28, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today announces the completion of all cohorts for its Phase I Single Ascending Dosing (SAD) and Multiple Ascending Dosing (MAD) clinical trial. Odyssey’s trial involved administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects. Throughout the trial, the drug was...

Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial, Cohort II

Sep 13, 2022

Las Vegas, NV, Sept. 13, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today announced the successful completion of safety measures for the second cohort of their Phase I Multi-Day Ascending Dosing (MAD) clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects to determine drug safety. For...

Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial

Aug 18, 2022

Las Vegas, NV, August 18, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International Inc., a company focused on developing unique, life-enhancing medical products, today announced the successful completion of safety measures for their Phase I Multi-Day Ascending Dosing (MAD) clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects. For MAD Cohort I, the drug was safe and well...

PURA Anticipated Cash Infusion Expected To Fuel Cannabis Market Strategy Transition

Aug 16, 2022

Dallas, Texas, August 16, 2022 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today announced an agreement remains in the works that is anticipated to result in a cash infusion within the next 90 days. Management expects the cash infusion to fuel a transition of the company’s overall cannabis market strategy. The marijuana cultivation license recently announced by PURA’s sister company, North American Cannabis Holding’s Inc. (OTC Pink: USMJ) has triggered an overall initiative for PURA...

PURA Announces New Development Expanding Cannabis Market Opportunity

Aug 10, 2022

Dallas, Texas, August 10, 2022 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today announced a new development that creates new opportunity for the company and could alter the course of the company in a new direction. The company confirms, as previously announced, an agreement still in the works anticipated to result in a cash infusion within the next 90 days. Management indicates the agreement is progressing on track and anticipated to be completed on or ahead of schedule. The new...

Odyssey Health, Inc. Announces Positive Results from Its Phase I Multi-Day Ascending Dosing for the Treatment of Concussion

Aug 10, 2022

Las Vegas, NV, August 10, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-improving medical products, today announces the completion and safety findings from Cohort I of its Multi-Day Ascending Dosing (MAD) arm for its Phase I Clinical Trial. Odyssey’s trial is administering PRV-002, its novel drug to treat concussion, to healthy human subjects. MAD Cohort I subjects were dosed for five...

Odyssey Health, Inc. Launches New Corporate Website

Aug 4, 2022

Las Vegas, NV, August 04, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-saving medical products, is pleased to announce the launch of its new innovative corporate website: https://www.odysseyhealthinc.com/. The new corporate website, like the Company’s previously announced name change, was designed to not only better reflect Odyssey Health’s mission and focus, but also improve communication...

Sipp Industries Receives Order for Delta-8 Infused Sauces from Uncle Stu’s Vape & Smoke Shop

Aug 2, 2022

Sipp Industries and Uncle Stu’s set to co-sponsor tasting and sampling event in the Greater Chicago area COSTA MESA, CA, August 02, 2022 -- McapMediaWire -- Sipp Industries, Inc. (OTC Pink: SIPC), a multifaceted corporation specializing in manufacturing, and distribution of commercial and consumer products in the cannabis industry, announces it has received an initial order for its newly launched Delta-8 (“D8”) infused sauces. Earlier this year, Sipp Industries launched a new...

Gold River Productions, Inc. (GRPS) announces test launch, marketing of new products, targeting relief for 1001 Veterans

Jul 12, 2022

Palm Coast, FL, July 12, 2022 -- McapMediaWire -- Gold River Productions, Inc. (OTC Pink: GRPS) (“GRPS”) (www.grpsinc.com) announces 1001 Veterans Relief Program in conjunction with Epidemiologic Solutions, (www.epidemiologicsolutions.com). “It’s about time!” says Chairman of the Board, Richard Goulding, M.D. “And the timing couldn’t be better. We have a campaign with the help of our 501c(3) affiliate, Epidemiologic Solutions to deliver urgent relief to our treasured...

Odyssey Health, Inc. Successfully Completes Phase I Single Ascending Dosing for Intranasal Concussion Drug

Jul 12, 2022

Las Vegas, NV, July 12, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-enhancing medical products, today announced the completion of all three cohorts in their Phase I Single Ascending Dosing (SAD) clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects. For SAD, the drug was safe and well tolerated. Concussions...

Odyssey Health, Inc. Completes Safety Evaluation of Cohort II for Concussion Drug

Jun 29, 2022

Las Vegas, NV, June 29, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-saving medical products, today announced positive safety findings from Cohort II of their Phase I clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects. Data from Cohort II indicates that the drug was safe and well-tolerated. The trial is...

Categories

Mcap MediaWire - Costumer Service

Translate »